Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This is an open label, phase II study in which cetuximab with concurrent thoracic
radiotherapy followed by consolidation chemotherapy with paclitaxel/carboplatin/cetuximab
will be administered to subjects with locally advanced NSCLC.